SOURCE: Bausch + Lomb

Bausch + Lomb

April 15, 2010 10:05 ET

Crystalens® AO Receives NTIOL Classification From CMS

ALISO VIEJO, CA--(Marketwire - April 15, 2010) -  Crystalens® AO has received new technology intraocular lens (NTIOL) classification from the U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS). The Crystalens AO, the first accommodating intraocular lens (IOL) with aspheric optics, was approved by the FDA in late 2009 and is the only presbyopia-correcting IOL with NTIOL classification.

The NTIOL classification became effective April 9 and means that Crystalens AO IOLs are approved for an additional $50 Medicare payment adjustment for services in conjunction with cataract procedures performed at an ambulatory surgical center (ASC).

"We are pleased that the Crystalens AO has been included into the active new technology IOL class for reduced spherical aberration. We believe that this decision should benefit surgeons and their patients in the coming months," said Andy Corley, global president, Surgical, Bausch + Lomb.

Approximately 3 million cataract surgeries are performed in the U.S. every year. A cataract is a clouding on the normally clear lens in the eye. When one forms, the natural lens in the patient's eye is replaced by an intraocular lens. Research indicates that only a small fraction of people realize that not all intraocular lenses are the same. The research also indicates that a number of patients are willing to pay a little extra money in order to get the best quality vision.

Crystalens is the only FDA-approved accommodating intraocular lens. Unlike the standard cataract replacement lenses, Crystalens is designed to not only eliminate the patient's cataract but also to give patients full range of vision so that they can see near, far and everything in between. Many Crystalens patients hardly if ever need their glasses or contacts again.

For more information about the Crystalens, please visit or call 1.877.7.SEEBETTER.

About Bausch + Lomb
Bausch + Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch + Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at

®/TM denote trademarks of Bausch & Lomb Incorporated.

Contact Information

  • News Media Contact:
    Ed Coghlan
    Coghlan Consulting for Bausch + Lomb
    818-489-4774 or